Therefore, this study aimed to identify the subpopulations who could benefit most from folic acid treatment in reducing the first stroke risk through simultaneous consideration of MTHFR C677T genotypes and platelet activation parameters in hypertensive patients. The gene discussed is MTHFR; the disease is Stroke.